Cruzain: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 6: | Line 6: | ||
Cru inhibitors are being investigated for therapeutic use against Chagas disease. | Cru inhibitors are being investigated for therapeutic use against Chagas disease. | ||
== Structural highlights == | |||
Cru catalytic triad is Cys-His-Asn. | |||
</StructureSection> | </StructureSection> |
Revision as of 14:30, 15 December 2015
Cruzain (Cru) is the major cysteine protease present in Trypanosoma cruzi which is the parasite causing Chagas disease. [1] RelevanceCru inhibitors are being investigated for therapeutic use against Chagas disease. Structural highlightsCru catalytic triad is Cys-His-Asn.
|
|
3D structures of cruzain3D structures of cruzain
Updated on 15-December-2015
1aim, 2aim, 1me3, 1me4 – Cru catalytic domain + methylketone inhibitor – Trypanosoma cruzi
1f29, 1f2a, 1f2b, 1f2c, 1ewo, 3lxs - Cru catalytic domain + vinyl sulfone derived inhibitor
1ewl, 1ewm – Cru catalytic domain + methylbutane inhibitor
1ewp - Cru catalytic domain + MOR-Leu-HPQ